EGM
Engineers Gate Manager Portfolio holdings
AUM
$8.04B
1-Year Return
12.21%
This Quarter Return
+2.6%
1 Year Return
+12.21%
3 Year Return
+28.21%
5 Year Return
+42.98%
10 Year Return
+180.06%
AUM
$5.75B
AUM Growth
+$622M
(+12%)
Cap. Flow
+$579M
Cap. Flow
% of AUM
10.08%
Top 10 Holdings %
Top 10 Hldgs %
7.33%
Holding
2,680
New
612
Increased
791
Reduced
767
Closed
502
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$101M |
| 2 |
CVS Health
CVS
|
+$33M |
| 3 |
Uber
UBER
|
+$27.7M |
| 4 |
Booking.com
BKNG
|
+$25.8M |
| 5 |
Medtronic
MDT
|
+$23.2M |
Top Sells
| 1 |
Costco
COST
|
+$23.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$22.9M |
| 3 |
Jabil
JBL
|
+$20.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$19.6M |
| 5 |
Spotify
SPOT
|
+$19.6M |
Sector Composition
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 14.8% |
| 3 | Industrials | 14.69% |
| 4 | Healthcare | 12.33% |
| 5 | Financials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Scholar Rock
SRRK
$3.04B
| $296K | 0.01% |
6,857
-20,927
| -75% | -$904K |
|
1702
Praxis Precision Medicines
PRAX
$794M
| $296K | 0.01% |
3,850
-887
| -19% | -$68.3K |
|
1703
Backblaze
BLZE
$534M
| $295K | 0.01% |
49,012
-10,156
| -17% | -$61.1K |
|
1704
Penumbra
PEN
$10.6B
| $294K | 0.01% |
+1,240
| New | +$294K |
|
|
TIGR
1705
UP Fintech Holding
TIGR
$2B
| $294K | 0.01% |
+45,510
| New | +$294K |
|
1706
Aveanna Healthcare
AVAH
$1.76B
| $294K | 0.01% |
64,292
+25,723
| +67% | +$118K |
|
|
SVC
1707
Service Properties Trust
SVC
$476M
| $292K | 0.01% |
115,073
+60,368
| +110% | +$153K |
|
1708
Allete
ALE
$3.67B
| $291K | 0.01% |
4,495
+455
| +11% | +$29.5K |
|
1709
Harmony Gold Mining
HMY
$9.34B
| $291K | 0.01% |
+35,465
| New | +$291K |
|
1710
Inspire Medical Systems
INSP
$2.37B
| $291K | 0.01% |
1,569
-1,530
| -49% | -$284K |
|
1711
Virtus Investment Partners
VRTS
$1.34B
| $291K | 0.01% |
1,318
+132
| +11% | +$29.1K |
|
1712
Kyndryl
KD
$7.39B
| $291K | 0.01% |
8,400
-46,685
| -85% | -$1.62M |
|
1713
Bowman Consulting
BWMN
$703M
| $290K | 0.01% |
+11,638
| New | +$290K |
|
1714
Celldex Therapeutics
CLDX
$1.62B
| $290K | 0.01% |
11,489
-26,997
| -70% | -$682K |
|
1715
Repligen
RGEN
$6.39B
| $290K | 0.01% |
2,014
-8,432
| -81% | -$1.21M |
|
|
AMED
1716
DELISTED
Amedisys
AMED
| $289K | 0.01% |
3,187
| – | – |
|
1717
Banco Santander Chile
BSAC
$12.1B
| $289K | 0.01% |
15,337
+5,467
| +55% | +$103K |
|
1718
Kingstone Companies
KINS
$195M
| $288K | 0.01% |
+18,972
| New | +$288K |
|
|
FINV
1719
FinVolution Group
FINV
$1.9B
| $288K | 0.01% |
42,358
+27,789
| +191% | +$189K |
|
1720
Janux Therapeutics
JANX
$1.45B
| $287K | 0.01% |
+5,352
| New | +$287K |
|
1721
Vermilion Energy
VET
$1.14B
| $286K | 0.01% |
+30,429
| New | +$286K |
|
1722
First Financial Corporation Common Stock
THFF
$691M
| $286K | 0.01% |
+6,186
| New | +$286K |
|
1723
Dorman Products
DORM
$4.93B
| $285K | 0.01% |
2,202
-836
| -28% | -$108K |
|
1724
Atmos Energy
ATO
$26.7B
| $284K | ﹤0.01% |
+2,041
| New | +$284K |
|
1725
BlueLinx
BXC
$617M
| $284K | ﹤0.01% |
+2,782
| New | +$284K |
|